Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

108.24
+1.191.11%
Post-market: 108.240.00000.00%18:16 EDT
Volume:601.59K
Turnover:65.25M
Market Cap:6.55B
PE:14.41
High:109.43
Open:106.94
Low:106.56
Close:107.05
Loading ...

Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak

Zacks
·
23 Apr

3 Small-Cap Stocks in the Doghouse

StockStory
·
23 Apr

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

THOMSON REUTERS
·
23 Apr

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

PR Newswire
·
23 Apr

Jazz Pharmaceuticals Completes Acquisition of Chimerix

THOMSON REUTERS
·
22 Apr

Jazz Pharmaceuticals Completes Acquisition of Chimerix

PR Newswire
·
22 Apr

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

Zacks
·
21 Apr

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Zacks
·
21 Apr

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Zacks
·
17 Apr

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Zacks
·
17 Apr

Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag

Zacks
·
15 Apr

Ironwood Shares Tank on Regulatory Update for Apraglutide

Zacks
·
15 Apr

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate

Zacks
·
11 Apr

TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why

Zacks
·
10 Apr

Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?

Zacks
·
10 Apr

Jazz Pharmaceuticals Price Target Maintained With a $210.00/Share by Needham

Dow Jones
·
10 Apr

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Simply Wall St.
·
09 Apr

Jazz Pharma to pay $145 million to settle narcolepsy drug antitrust case

Reuters
·
09 Apr

Jazz Pharmaceuticals Plc - to Record $145 Million Pre-Tax Charge in Q1 2025 - SEC Filing

THOMSON REUTERS
·
09 Apr

Jazz Pharmaceuticals- Co's Unit Enters Preliminary Class Settlement Agreement With Class of Indirect Xyrem Purchasers - SEC Filing

THOMSON REUTERS
·
09 Apr